|
On February 26, 2009 the FDA added a "Black Box Warning" to the gastrointestinal drug Reglan (metoclopramide) and it's wide array of products including tablets, disintegrating tablets, orals solutions and injections due to serious side effects from the drug, most notably Tardive Dyskinesia and Neuroleptic Malignant Syndrome (NMS). The new black box warning states that if Reglan is taken for an extended period of time, a patient may be at a greater risk of developing Tardive Dyskinesia, NMS and other serious side effects.
Reglan is a pharmaceutical drug prescribed to patients suffering from gastro esophageal reflux and was approved by the FDA for short-term use (4 to 12 weeks). In spite of that fact, approximately one-third of patients are being prescribed Reglan for 12 months or longer to deal with their heartburn or reflux. Reglan has also been prescribed for use in babies, with many doctors assuring parents of the drug’s safety and lack of side effects, which, as the black box warning suggests, simply is not the case.
Symptoms of Tardive Dyskinesia include: involuntary, repetitive movements of the extremities, including lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no know treatment. Neuroleptic Malignant Syndrome (NMS) is a potentially fatal syndrome involves hyperthermia, altered consciousness, muscular rigidity, and autonomic dysfunction.
If you, your family or someone you know has been injured by Reglan, contact us now for a free, private consultation. Knowledge is power - we'd like to help you!
CLICK HERE to contact us today, or send an email to Info@HelpingTheInjured.com
|
